학술논문

From Diagnostic‐Therapeutic Pathways to Real‐World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR‐Positive Non‐Small Cell Lung Cancer (MOST Study).
Document Type
Article
Source
Oncologist; Jun2019, Vol. 24 Issue 6, pe318-e326, 9p, 2 Diagrams, 1 Chart, 4 Graphs
Subject
LUNG cancer diagnosis
LUNG cancer & genetics
LUNG cancer prognosis
GEFITINIB
DRUGS
EPIDERMAL growth factor
LONGITUDINAL method
LUNG cancer
MEDICAL care costs
MEDICAL cooperation
GENETIC mutation
SCIENTIFIC observation
PATIENT compliance
PATIENT monitoring
RESEARCH
SURVIVAL
TREATMENT effectiveness
ERLOTINIB
THERAPEUTICS
Language
ISSN
10837159
Abstract
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)